MT 4 McNEIL (Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease)
Generic Name: pancrelipase
Pill with imprint MT 4 McNEIL is Yellow / Clear, Capsule-shape and has been identified as Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease. It is supplied by Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Pancreaze is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).
Images for MT 4 McNEIL
Pancreaze
- Generic Name
- pancrelipase
- Imprint
- MT 4 McNEIL
- Strength
- 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease
- Color
- Yellow / Clear
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Digestive enzymes
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ortho-McNeil-Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0341 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
silicon dioxide,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
triethyl citrate,
magnesium silicate,
dimethicone,
gelatin,
titanium dioxide,
sodium lauryl sulfate,
sorbitan monolaurate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "MT 4 McNEIL"
More about Pancreaze (pancrelipase)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1)
- Drug images
- Pricing & coupons
- En español
- Drug class: digestive enzymes
- FDA approval history
Patient resources
- Other brands
- Creon, Zenpep, Viokace, Pertzye, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.